Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea
Open Access
- 4 August 2015
- journal article
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 6 (4), 249-255
- https://doi.org/10.1016/j.phrp.2015.07.003
Abstract
The purpose of this study is to analyze the influence of the corporate governance of pharmaceutical companies on research and development (R&D) investment.Keywords
This publication has 20 references indexed in Scilit:
- Foreign and domestic ownership, business groups, and firm performance: evidence from a large emerging marketStrategic Management Journal, 2006
- OWNERSHIP STRUCTURES AND R&D INVESTMENTS OF U.S. AND JAPANESE FIRMS: AGENCY AND STEWARDSHIP PERSPECTIVES.The Academy of Management Journal, 2003
- BIDDING WARS OVER R&D-INTENSIVE FIRMS: KNOWLEDGE, OPPORTUNISM, AND THE MARKET FOR CORPORATE CONTROL.The Academy of Management Journal, 2003
- CONFLICTING VOICES: THE EFFECTS OF INSTITUTIONAL OWNERSHIP HETEROGENEITY AND INTERNAL GOVERNANCE ON CORPORATE INNOVATION STRATEGIES.The Academy of Management Journal, 2002
- Variations in ownership behavior and propensity to diversify: a study of the Indian corporate contextStrategic Management Journal, 2002
- THE INFLUENCE OF ACTIVISM BY INSTITUTIONAL INVESTORS ON R&D.The Academy of Management Journal, 2001
- Ownership structure and economic performance in the largest european companiesStrategic Management Journal, 2000
- Do foreign investors destabilize stock markets? The Korean experience in 1997Journal of Financial Economics, 1999
- Are institutional investors myopic? A time‐series study of four technology‐driven industriesStrategic Management Journal, 1991
- Theory of the firm: Managerial behavior, agency costs and ownership structureJournal of Financial Economics, 1976